Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

Javelin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

 

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 17
ISBN Number not applicable
Product Code GMD02161

Price

£82.00
approximately: $126 | €91

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Javelin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Javelin Pharmaceuticals, Inc. (Javelin) is a specialty pharmaceutical company focused on the development of new drugs and improved formulations of existing drugs with its innovative proprietary technologies that target current unmet and underserved medical need in the pain management market. It has product candidates for acute moderate-to-severe pain, post-operative pain, orthopedic injury pain, procedural pain, burn pain and trauma. It has three late stage product candidates in development, namely, Dyloject, Rylomine, and Ereska. The company is headquartered in Cambridge, Maryland, the United States

Global Markets Direct's Javelin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Javelin Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • List of Tables
  • List of Figures
    • Key Facts
    • Business Description
    • Major Products and Services
    • History
    • SWOT Analysis
    • SWOT Analysis - Overview
    • Javelin Pharmaceuticals, Inc. - Strengths
    • Javelin Pharmaceuticals, Inc. - Strengths - Strong Patent Portfolio
    • Javelin Pharmaceuticals, Inc. - Strengths - Focused Research and Development
    • Javelin Pharmaceuticals, Inc. - Weaknesses
    • Javelin Pharmaceuticals, Inc. - Weaknesses - Losses
    • Javelin Pharmaceuticals, Inc. - Weaknesses - Reliance on Third Party Manufacturers
    • Javelin Pharmaceuticals, Inc. - Opportunities
    • Javelin Pharmaceuticals, Inc. - Opportunities - Partnership with Therabel Pharma N.V
    • Javelin Pharmaceuticals, Inc. - Opportunities - Pipeline Products
    • Javelin Pharmaceuticals, Inc. - Opportunities - Emerging Markets
    • Javelin Pharmaceuticals, Inc. - Threats
    • Javelin Pharmaceuticals, Inc. - Threats - Tightening of FDA's Regulatory Oversight
    • Javelin Pharmaceuticals, Inc. - Threats - Intense Competition
    • Javelin Pharmaceuticals, Inc. - Threats - Changing Political Climate in the US
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Company Statement
    • Locations And Subsidiaries
    • Locations And Subsidiaries - Head Office
    • Locations And Subsidiaries - Other Locations & Subsidiaries
    • Financial Ratios
    • Financial Ratios - Capital Market Ratios
    • Financial Ratios - Annual Ratios
    • Financial Ratios - Interim Ratios
    • Financial Ratios - Ratio Charts
  • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Javelin Pharmaceuticals, Inc., Key Facts
    • Major Products and Services
    • Javelin Pharmaceuticals, Inc., History
    • Javelin Pharmaceuticals, Inc., Key Employees
    • Javelin Pharmaceuticals, Inc., Key Employee Biographies
    • Javelin Pharmaceuticals, Inc., Other Locations
    • Javelin Pharmaceuticals, Inc., Subsidiaries
    • Javelin Pharmaceuticals, Inc., Ratios based on current share price
    • Javelin Pharmaceuticals, Inc., Annual Ratios
    • Javelin Pharmaceuticals, Inc., Interim Ratios
    • Currency Codes
    • Capital Market Ratios
    • Equity Ratios
    • Profitability Ratios
    • Cost Ratios
    • Liquidity Ratios
    • Leverage Ratios
    • Efficiency Ratios
  • List of Figures
    • Javelin Pharmaceuticals, Inc., Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis